Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid versus corticosteroid injection for plantar fasciitis
PACTR202401785557046Phase 4Not yet recruiting
- Sponsor
- Mohammed VI University Hospital
- Start
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hyaluronic acid in plantar fasciitis (2 arms), sponsored by Mohammed VI University Hospital. Primary endpoint: Pain intensity. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
hyaluronic acid
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on PACTR202401785557046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401785557046.